Business Context and Reporting Period
This Form 8-K was filed by AgriForce Growing Systems, Ltd., although the request metadata identifies AVAX ONE TECHNOLOGY LTD.; the entity name should be verified. The report concerns a Securities Purchase Agreement entered into on June 30, 2022, and was signed and filed on July 6, 2022. The company is incorporated in British Columbia and its common shares and Series A warrants trade on Nasdaq under AGRI and AGRIW.
Transaction and Key Financial Terms
- Initial issuance: $14.025 million principal amount of debentures and accompanying warrants.
- Expected initial gross proceeds: $12.75 million, before fees, expected on July 6, 2022.
- Additional financing: Investors may purchase up to $33.0 million of additional debentures and warrants, in one or more tranches of at least $5 million, subject to conditions and investor discretion.
- Debenture conversion price: $2.22 per share initially.
- Maturity: 2.5 years from June 30, 2022, with a possible six-month extension upon payment of six months of interest at 8% per annum at the end of the 18th month.
- Interest: 5% for the first 12 months, 6% for the next 12 months, and 8% thereafter until maturity.
- Original issue discount: 10%.
- Amortization: Begins September 1, 2022, over 25 months. Payments are required in cash for the first 12 months and may thereafter be made in cash or stock, subject to specified equity conditions.
- Warrants: 3.5-year warrants with 65% warrant coverage and an initial exercise price of $2.442 per share, subject to customary adjustments and a price-ratchet provision.
Material Changes and Capital Structure Effects
- The transaction creates a material direct financial obligation and introduces scheduled principal amortization and interest payments.
- Conversion of the debentures and exercise of the warrants could substantially dilute existing shareholders. Until required shareholder approvals are obtained, issuances are capped at 19.9% of outstanding common shares, subject to the transaction documents and Nasdaq rules.
- Investors are subject to 4.99% or 9.99% beneficial ownership exercise limitations.
- The debentures and warrants include dilution protection, including adjustments for certain lower-priced equity issuances and reverse stock splits.
- The company’s subsidiaries provided guarantees of the company’s obligations, and officers and directors agreed to one-year lockups on their company shares, subject to specified exceptions.
Liquidity, Outlook, Risks, and Unusual Items
- The filing indicates expected gross funding of $12.75 million, but does not provide a clear net proceeds amount after fees or a detailed use of proceeds.
- Future access to the additional $33.0 million is discretionary for the investors and subject to conditions; it is not assured.
- Cash repayment obligations increase beginning September 1, 2022. Stock-based repayment after the first 12 months is permitted only if conditions including trading volume, an effective resale registration statement, absence of default, and Nasdaq compliance are satisfied.
- The company must file a resale registration statement on Form S-1 generally within 30 days and obtain effectiveness generally within 60 days, or within 90 days if subject to full SEC review. Failure to meet deadlines may result in penalties of 2% of the subscription amount per month, capped at 10%.
- The financing and related issuances, including subsequent tranches, require shareholder approval together with approval of the Delphy acquisition to remove the 19.9% issuance limitation.
- The filing contains customary covenants, negative covenants, events of default, and forward-looking statement risk disclosures. It does not provide revenue, profit, cash flow, margin, balance-sheet debt, or liquidity metrics for the reporting period.
- The filing states that the securities were sold in private placements exempt from registration under Section 4(a)(2) of the Securities Act.
Investor Verification Items
- Confirm the correct registrant, because the supplied metadata names AVAX ONE TECHNOLOGY LTD., while the filing names AgriForce Growing Systems, Ltd.
- Verify whether the initial $12.75 million was funded on July 6, 2022 and determine actual net proceeds after fees.
- Review the executed SPA, debentures, warrants, registration rights agreement, guarantees, and lockup agreements for final terms and conditions.
- Assess the company’s ability to meet interest and amortization obligations beginning September 2022.
- Determine whether shareholders approved the financing, subsequent tranches, and the Delphy acquisition, and whether the 19.9% issuance cap remains applicable.
- Monitor the Form S-1 filing and effectiveness deadlines and any registration penalties.
- Quantify potential dilution under debenture conversion, warrant exercise, price-ratchet adjustments, and stock-based amortization.